Business● Low26m ago · Nov 10, 2026, 1:21 AM
P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M as it targets $200M in value creation
GlobeAlert Desk · curated from Seeking Alpha Tech · global
P3 Health Partners has increased its adjusted EBITDA guidance range for 2026 to $90M-$110M. The company aims for $200M in value creation, reflecting updated financial projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business15m agoOccidental Petroleum signs pair of CO2 offtake agreements for Permian Basin operationsSeeking Alpha TechBusiness26m agoOdyssey cruise ship’s voyage ends in Singapore arrest after owner goes bustSouth China Morning PostBusiness45m agoExxon signs MoU to explore oil opportunities in formerly 'uninvestable' VenezuelaSeeking Alpha TechBusiness45m agoAmeresco outlines 12 to 18 months timeline to convert five data center projects to contracted backlogSeeking Alpha Tech